Tag Archives: aspirin risk

Meta-analysis examines whether aspirin is worth the risk for primary prevention

Despite clinically relevant reductions in nonfatal myocardial infarction (MI), the use of aspirin in patients without a history of cardiovascular disease (CVD) does not lead to reductions in either cardiovascular- or cancer-related death, according to a recently published meta-analysis. The incidence of CVD in India is on the rise and… 

Read more »
Posted in Cardiology, Cardiovascular Disease, Pharmacology | Also tagged , , , , , , , , | Volume: | Leave a comment